Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)

NCT00503178 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT00503178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00503178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
April 1, 2006
Completion date
April 22, 2015
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases